Pivotal bioVenture Partners

Pivotal bioVenture Partners is a San Francisco-based venture capital firm that focuses on investing in early-stage biotechnology companies in North America and Europe. Established in 2017, the firm targets innovative therapeutic products and platforms aimed at addressing significant unmet medical needs. Pivotal bioVenture Partners invests at various stages of a company's development, from inception through mid and late-stage clinical development. The firm's team possesses a diverse range of expertise in venture capital, company building, and drug discovery, enabling them to effectively collaborate with entrepreneurs to advance their business objectives.

Rob Hopfner

Managing Director and Partner

Ash Khanna

Partner, Board Member HotSpot Tx, Bolt Bio, Fountain Tx and Evommune

Jeni Lee

Partner

Past deals in Macau

SanReno Therapeutics

Funding Round in 2021

SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.